Lanean...
Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease
Huntington's disease (HD) is a hereditary neurodegenerative condition with no therapeutic intervention known to alter disease progression, but several trials are ongoing and biomarkers of disease progression are needed. Tau is an axonal protein, often altered in neurodegeneration, and recent st...
Gorde:
| Argitaratua izan da: | J Neurochem |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5053298/ https://ncbi.nlm.nih.gov/pubmed/27344050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jnc.13719 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|